Financhill
Buy
57

BMRN Quote, Financials, Valuation and Earnings

Last price:
$58.85
Seasonality move :
3.2%
Day range:
$58.74 - $61.26
52-week range:
$52.93 - $94.85
Dividend yield:
0%
P/E ratio:
22.24x
P/S ratio:
4.01x
P/B ratio:
1.98x
Volume:
1.5M
Avg. volume:
1.9M
1-year change:
-26.9%
Market cap:
$11.5B
Revenue:
$2.9B
EPS (TTM):
$2.69

Earnings Data

Next earnings date for BMRN
Aug 05
2025
Most recent earnings per share
$0.95
Missed by $0.00
(May 1/2025)
Consensus Estimate
$0.95
(May 1/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BMRN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/05/2025 Q2 $761.9M -- -- $1.03 --
05/01/2025 Q1 $738.7M $745.1M $0.95 $0.95 -$0.00
02/19/2025 Q4 $711M $747.3M $0.64 $0.74 -$0.10
10/29/2024 Q3 $703.3M $745.7M $0.55 $0.79 -$0.24
08/05/2024 Q2 $664M $712M $0.55 $0.60 -$0.05
04/24/2024 Q1 $651.8M $648.8M $0.46 $0.60 -$0.14
02/22/2024 Q4 $636.9M $646.2M $0.11 $0.45 -$0.34
11/01/2023 Q3 -- -- $0.21 $0.48 -$0.27
07/31/2023 Q2 -- -- $0.29 $0.47 -$0.18
04/26/2023 Q1 -- -- $0.27 $0.40 -$0.13
02/27/2023 Q4 -- -- -$0.00 $0.39 -$0.39
10/26/2022 Q3 -- -- -$0.04 $0.43 -$0.47
08/03/2022 Q2 -- -- $0.15 $0.53 -$0.38
04/27/2022 Q1 -- -- $0.63 $0.46 $0.18
02/23/2022 Q4 -- -- -$0.32 -$0.01 -$0.31
10/27/2021 Q3 -- -- -$0.20 $0.09 -$0.29
07/28/2021 Q2 -- -- $0.07 $0.25 -$0.18
04/29/2021 Q1 -- -- $0.09 $0.30 -$0.21
02/25/2021 Q4 -- -- $0.12 $0.18 -$0.06
11/05/2020 Q3 -- -- $4.01 $0.26 $3.75
08/04/2020 Q2 -- -- -$0.16 $0.20 -$0.36
04/30/2020 Q1 -- -- $0.44 $0.33 $0.11
02/26/2020 Q4 -- -- $0.08 $0.24 -$0.16
10/23/2019 Q3 -- -- $0.30 $0.34 -$0.04
08/01/2019 Q2 -- -- -- $0.19 --
04/25/2019 Q1 -- -- -- $0.10 --
02/21/2019 Q4 -- -- -- $0.12 --
10/25/2018 Q3 -- -- -- $0.15 --
08/02/2018 Q2 -- -- -- -- --
04/25/2018 Q1 -- -- -- -- --
02/22/2018 Q4 -- -- -- -- --
10/26/2017 Q3 -- -- -- -- --
08/02/2017 Q2 -- -- -- -- --
05/04/2017 Q1 -- -- -- -- --
02/23/2017 Q4 -- -- -- -- --
10/27/2016 Q3 -- -- -- -- --
08/04/2016 Q2 -- -- -- -- --
04/12/2016 Q1 -- -- -- -- --
02/25/2016 Q4 -- -- -- -- --
10/29/2015 Q3 -- -- -- -- --
08/03/2015 Q2 -- -- -- -- --

Biomarin Pharmaceutical Earnings Questions

  • How Much did Biomarin Pharmaceutical Generate in Revenue Last Quarter?

    Biomarin Pharmaceutical reported $745.1M worth of top line sales in its most recent quarter.

  • Did Biomarin Pharmaceutical Beat Earnings Last Quarter?

    Biomarin Pharmaceutical announced earnings per share of $0.95 which represents a miss of analyst forecast a $0.95 per share.

  • Is Biomarin Pharmaceutical Profitable?

    Biomarin Pharmaceutical reported $593.6M that represents $3.02 per share over the last quarter.

  • What is the Analyst Consensus for Biomarin Pharmaceutical EPS Next Year?

    Biomarin Pharmaceutical's earnings are forecast to grow from $2.21 per share to $3.30 per share next year representing an increase of 94.87%.

  • When is Biomarin Pharmaceutical's Earnings Date?

    Biomarin Pharmaceutical's next earnings date is August 5, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Is a Millionaire-Maker Stock?
What Is a Millionaire-Maker Stock?

From time to time, investors will run across the term…

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Is BYD a Threat To Tesla Shareholders?
Is BYD a Threat To Tesla Shareholders?

BYD (OTC:BYDDY) has rocketed to the top of China’s booming…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
99
DAVE alert for May 9

Dave [DAVE] is up 9.31% over the past day.

Buy
52
QDEL alert for May 9

QuidelOrtho [QDEL] is down 0.22% over the past day.

Buy
61
TPC alert for May 9

Tutor Perini [TPC] is up 9.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock